Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of showering shortly after AndroGel application on plasma testosterone levels
NL-OMON32664Phase 4Recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of AndroForte in Hypogonadism, sponsored by Vrije University Medical Center. Primary endpoints: maximal testosterone level, area under the curve and 1 more. Started Jan 2009; status: recruiting.
02
Drugs
AndroForte
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NL-OMON32664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32664.